Mark Rothera - 19 Sep 2022 Form 3 Insider Report for Viracta Therapeutics, Inc. (VIRX)

Signature
/s/ Daniel Chevallard, as Attorney-in-Fact
Issuer symbol
VIRX
Transactions as of
19 Sep 2022
Net transactions value
$0
Form type
3
Filing time
19 Sep 2022, 18:54:00 UTC
Next filing
17 Mar 2023

No securities are beneficially owned.

Remarks:

No securities beneficially held.